![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
Waggoner Center for Alcohol and Addiction Research and the Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas (J.O., M.S., R.A.H.); Department of Anesthesia, Kyoto University Hospital, Kyoto, Japan (T.N.); and Department of Physiology and Neuroscience, Medical University of South Carolina, Charleston, South Carolina (C.T.S., J.J.W.).
Alcohols, inhaled anesthetics, and some injectable anesthetics inhibit the function of N-methyl-D-aspartate (NMDA) receptors, but the mechanisms responsible for this inhibition are not fully understood. Recently, it was shown that ethanol inhibition of NMDA receptors was reduced by mutation of residues in the transmembrane (TM) segment 3 of the NR1 subunit (F639A) or in TM4 of the NR2A subunit (A825W), suggesting putative ethanol binding sites. We hypothesized that the actions of other anesthetics might also require these amino acids and evaluated the effects of anesthetics on the NMDA receptors expressed in Xenopus oocytes with two-electrode voltage-clamp recording. Effects of hexanol, octanol, isoflurane, halothane, chloroform, cyclopropane, 1-chloro-1,2,2-trifluorocyclobutane, and xenon were reduced or eliminated in the mutant NMDA receptors, whereas the inhibitory effects of nitrous oxide, ketamine, and benzene were not affected by these mutations. Rapid applications of glutamate and glycine by a T-tube device provided activation time constants, which suggested different properties of ketamine and isoflurane inhibition. Thus, amino acids in TM3 and TM4 are important for the actions of many anesthetics, but nitrous oxide, benzene, and ketamine seem to have distinct mechanisms for inhibition of the NMDA receptors.
Address correspondence to: Dr. R. Adron Harris, University of Texas, Waggoner Center for Alcohol and Addiction Research, 1 University Station A4800, Austin, TX 78712-0159. E-mail: harris{at}mail.utexas.edu
This article has been cited by other articles:
![]() |
P. S. Milutinovic, J. Zhao, and J. M. Sonner Tolerance to Isoflurane Does Not Occur in Developing Xenopus laevis Tadpoles Anesth. Analg., January 1, 2009; 108(1): 176 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Sonner A Hypothesis on the Origin and Evolution of the Response to Inhaled Anesthetics Anesth. Analg., September 1, 2008; 107(3): 849 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang and J. M. Sonner Anesthetic-Like Modulation of Receptor Function by Surfactants: A Test of the Interfacial Theory of Anesthesia Anesth. Analg., September 1, 2008; 107(3): 868 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jenkins, I. A. Lobo, D. Gong, J. R. Trudell, K. Solt, R. A. Harris, and E. I. Eger II General Anesthetics Have Additive Actions on Three Ligand Gated Ion Channels Anesth. Analg., August 1, 2008; 107(2): 486 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. U. Weigt, O. Adolph, M. Georgieff, E. M. Georgieff, and K. J. Fohr Evidence That Xenon Does Not Produce Open Channel Blockade of the NMDA Receptor J Neurophysiol, April 1, 2008; 99(4): 1983 - 1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang and J. M. Sonner The Anesthetic-Like Effects of Diverse Compounds on Wild-Type and Mutant {gamma}-Aminobutyric Acid Type A and Glycine Receptors Anesth. Analg., March 1, 2008; 106(3): 838 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Kelly, K. Solt, and D. E. Raines Volatile Aromatic Anesthetics Variably Impact Human {gamma}-Aminobutyric Acid Type A Receptor Function Anesth. Analg., November 1, 2007; 105(5): 1287 - 1292. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, J. Zhao, P. S. Milutinovic, R. J. Brosnan, E. I. Eger II, and J. M. Sonner Anesthetic Properties of the Ketone Bodies {beta}-Hydroxybutyric Acid and Acetone Anesth. Analg., September 1, 2007; 105(3): 673 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Smothers and J. J. Woodward Pharmacological Characterization of Glycine-Activated Currents in HEK 293 Cells Expressing N-Methyl-D-aspartate NR1 and NR3 Subunits J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 739 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Milutinovic, L. Yang, R. S. Cantor, E. I. Eger II, and J. M. Sonner Anesthetic-Like Modulation of a {gamma}-Aminobutyric Acid Type A, Strychnine-Sensitive Glycine, and N-Methyl-d-Aspartate Receptors by Coreleased Neurotransmitters Anesth. Analg., August 1, 2007; 105(2): 386 - 392. [Abstract] [Full Text] [PDF] |
||||